Harvard Business Review

MAY 20, 2014

In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. The current corporate entity is comprised of firms that used to be called: King Pharmaceuticals, Wyeth, American Cyanamid, Lederle, Pharmacia, Upjohn, Searle, SUGEN, Warner-Lambert, Parke-Davis and others.

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Trends 11

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. The hope was that the diversity of brainpower and perspectives would yield imaginative ways to outgrow the shortfall. The only questions the circle should avoid are what to do about current operational problems.

Leadership 11

Leadership Diversity Committee Long-term 11

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

JUNE 20, 2017

For organizations seeking to become more adaptive and innovative, culture change is often the most challenging part of the transformation. Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

OCTOBER 25, 2018

In fact, both the sectoral and the geographic diversity of superstar firms is greater today than 20 years ago. These “superstar” sectors include financial services such as banking, insurance, and asset management, professional services, internet and software, real estate, and pharmaceuticals and medical products.

Industry 13

Industry Company GDP Bottom-up 13

Harvard Business Review

DECEMBER 5, 2016

It serves vastly diverse populations: toddlers and caregivers, new immigrants, lifelong learners, famous novelists, and scholars. Library leaders knew that given the immense changes brought on by digital innovations, as well as shifts in the communities that the Library served, it would need to evolve. in less than five years.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. It also took into account their roles in changing patient behavior.

Productivity 8

Productivity Products Company Engineering 8

Strategy Driven

MARCH 18, 2011

Moreover, fixed assets are more difficult to leverage across diverse businesses than capabilities, and they tend to expire, become obsolete, or give way to related services. Companies today operate in a business environment that encourages incoherence. We call this measure the ‘coherence premium.’

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

MARCH 6, 2015

Mark, a ten-year veteran of the pharmaceutical R&D world with a Ph.D. So why, when given the chance to manage a larger, more diverse group of top performers, would he flame out so spectacularly? How do you leverage diverse talents, skills, and perspectives, getting the best from everyone?

Management 8

Management Self-aware Teamwork Pharmaceuticals 8

Harvard Business Review

JUNE 24, 2015

The f ive forces framework for strategy may be valid in one arena, blue ocean or open innovation in another, but each approach to strategy tends to be presented or perceived as a panacea. The firm can innovate to address a tired industry business model or can recognize a megatrend before others see and act on it.

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

NOVEMBER 28, 2017

Doing so entails operating more efficiently or innovating to create products that consumers value more. Anyone who owns or operates a business is well acquainted with the risks, sacrifices, and competitive pressures involved. In the sample of firms we used, KLD scores were positively correlated with firms’ incomes.

Company 8

Company Short-term Long-term Price 8

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. This is an incredible moment for innovation.

Innovation 13

Innovation Productivity Products Venture Capitalist 13